Ageing and respiratory infections: The airway of ageing

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 323-328

  Haq, Kamran ^a   McElhaney, Janet E ^a  

^a Advanced Medical Research Institute of Canada   (Canada)

Author keywords

Ageing; Immunity; Influenza; Vaccines

Indexed keywords

ADAPTIVE IMMUNITY; AGE; AGING; DISEASE PREDISPOSITION; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; INNATE IMMUNITY; RESPIRATORY TRACT INFECTIONS;

ADAPTIVE IMMUNITY; AGE FACTORS; AGING; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, INNATE; INFLUENZA, HUMAN; RESPIRATORY TRACT INFECTIONS;

EID: 84914148387     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.06.009     Document Type: Article

References (70)

1. McElhaney J.E., Effros R.B. Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol 2009, 21:418-424.
2. WHO (World Health Organization) Health Statistics and information systems: Definition of an older or elderly person 2014, http://www.who.int/healthinfo/survey/ageingdefnolder/en/.
3. UN (United Nations) World population ageing: 1950-2050 2002, United Nations Population Division. http://www.un.org/esa/population/publications/worldageing19502050.
4. WHO (World Health Organization) Chronic respiratory diseases: chronic obstructive pulmonary disease (COPD) 2011, http://www.who.int/respiratory/copd/en/.
5. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of aging. J Pathol 2007, 211:144-156.
6. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv Immunol 2002, 80:243-284.
7. Meyer K.C. Lung infections and aging. Ageing Res Rev 2004, 3:55-67.
8. Pawelec G., Larbi A., Derhovanessian E. Senescence of the human immune system. J Comp Pathol 2010, 142:S39-S44.
9. Staras S.A., Dollard S.C., Radford K.W., Flanders W.D., Pass R.F., Cannon M.J. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006, 43:1143-1151.
10. Wang G.C., Kao W.H., Murakami P., Xue Q.-L., Chiou R.B., Detrick B., et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 2010, 171:1144-1152.
11. Goto M. Inflammaging (inflammation+aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory?. Biosci Trends 2008, 2:218-230.
12. Meyer K.C., Ershler W., Rosenthal N., Lu X.G., Peterson K. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 1996, 153:1072-1079.
13. Bartlett D.B., Firth C.M., Phillips A.C., Moss P., Baylis D., Syddall H., et al. The age-related increase in low-grade systemic inflammation (inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012, 11:912-915.
14. Forsythe L.K., Wallace J.M., Livingstone M.B. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008, 21:117-133.
15. Maggio M., Basaria S., Ble A., Lauretani F., Bandinelli S., Ceda G.P., et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 2006, 91:345-347.
16. Baylis D., Bartlett D.B., Patel H.P., Roberts H.C. Understanding how we age: insights into inflammaging. Longev Healthspan 2013, 2:8.
17. Falsey A.R., McElhaney J.E., Beran J., van Essen G., Duval X., Esen M., et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis 2014, 209(12):1873-1881.
18. Mehta J., Walsh E., Mahadevia A.R., Falsey Risk factors for respiratory synctial virus illness among patients with chronic obstructive pulmonary disease. COPD 10 2013, 293-299.
19. Falsey A.R. Editorial commentary: respiratory syncytial virus: a global pathogen in an aging world. Clin Infect Dis 2013, 57:1078-1080.
20. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
21. Solana R., Tarazona R., Gayoso I., Lesur O., Dupuis G., Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 2012, 24:331-341.
22. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M., Quaglino D. The immune system in the elderly: III. Innate immunity. Immunol Res 1999, 20:117-126.
23. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333.
24. Agrawal A., Gupta S. Impact of aging on dendritic cell functions in humans. Ageing Res Rev 2011, 10:336-345.
25. Tan S.-Y., Cavanagh L.L., D'Advigor W., Shackel N., Fazekas de St Groth B., Weninger W. Phenotype and functions of conventional dendritic cells are not compromised in aged mice. Immunol Cell Biol 2012, 90:722-732.
26. Agrawal A., Agrawal S., Cao J.-N., Su H., Osann K., Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 2007, 178:6912-6922.
27. Zhao J., Zhao J., Legge K., Perlman S. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest 2011, 121:4921-4930.
28. Pereira L.F., de Souza A.P.D., Borges T.J., Bonorino C. Impaired in vivo CD4+ T cell expansion and differentiation in aged mice is not solely due to T cell defects: decreased stimulation by aged dendritic cells. Mech Ageing Dev 2011, 132:187-194.
29. Grolleau-Julius A., Harning E.K., Abernathy L.M., Yung R.L. Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res 2008, 68:6341-6349.
30. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010, 184:2518-2527.
31. Garbe K., Bratke K., Wagner S., Virchow J.C., Lommatzsch M. Plasmacytoid dendritic cells and their Toll-like receptor 9 expression selectively decrease with age. Hum Immunol 2012, 73:493-497.
32. Verschoor C.P., Johnstone J., Millar J., Dorrington M.G., Habibagahi M., Lelic A., et al. Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 2013, 93:633-637.
33. Xu Y.-P., Qi R.-Q., Chen W., Shi Y., Cui Z.-Z., Gao X.-H., et al. Aging affects epidermal Langerhans cell development and function and alters their miRNA gene expression profile. Aging (Albany NY) 2012, 4:742-754.
34. Scheurmann J., Treiber N., Weber C., Renkl A.C., Frenzel D., Trenz-Buback F., et al. Mice with heterozygous deficiency of manganese superoxide dismutase (SOD2) have a skin immune system with features of "inflamm-aging". Arch Dermatol Res 2014, 306:143-155.
35. Ogata K., Yokose N., Tamura H., An E., Nakamura K., Dan K. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997, 84:269-275.
36. Campos C., Pera A., Sanchez-Correa B., Alonso C., Lopez-Fernandez I., Morgado S., et al. Effect of age and CMV on NK cell subpopulations. Exp Gerontol 2014, 54:130-137.
37. Butcher S., Chahal H., Nayak L., Sinclair A., Henriquez N., Sapey E., et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 2001, 70:881-886.
38. Plackett T., Boehmer E., Faunce D., Kovacs E.J. Aging and innate immune cells. J Leukoc Biol 2004, 76:291-299.
39. Juthani-Mehta M., Guo X., Shaw A.C., Towle V., Ning Y., Wang X., et al. Innate immune responses in nutrophils of community dwelling and nursing home elders. Aging Sci 2014, 2:115.
40. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res Rev 2011, 10:379-388.
41. Lefebrve J., Haynes L. Aging of the CD4T cell compartment. Open Longev Sci 2012, 6:83-91.
42. Cavanagh M.M., Qi Q., Weyand C.M., Goronzy J.J. Finding balance: T cell regulatory receptor expression during aging. Aging Dis 2011, 2:398-413.
43. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176:6333-6339.
44. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27:2418-2425.
45. Shahid Z., Kleppinger A., Gentleman B., Falsey A.R., McElhaney J.E. Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine 2010, 28:6145-6151.
46. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Würzner R., et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005, 79:3675-3683.
47. Wagar L.E., Gentleman B., Pircher H., McElhaney J.E., Watts T.H. Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS ONE 2011, 6:e23698.
48. Rosenkranz D., Weyer S., Tolosa E., Gaenslen A., Berg D., Leyhe T., et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol 2007, 188:117-127.
49. Simone R., Zicca A., Saverino D. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age. J Leukoc Biol 2008, 84:1454-1461.
50. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
51. Stout-Delgado H.W., Du W., Shirali A.C., Booth C.J., Goldstein D.R. Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection. Cell Host Microbe 2009, 6:446-456.
52. Lee J.S., Lee W.-W., Kim S.H., Kang Y., Lee N., Shin M.S., et al. Age-associated alteration in naive and memory Th17 cell response in humans. Clin Immunol 2011, 140:84-91.
53. Frasca D., Blomberg B.B. Effects of aging on B cell function. Curr Opin Immunol 2009, 21:425-430.
54. Wu Y.C., Kipling D., Dunn-Walters D.K. Age-related changes in human peripheral blood IgH repetoire following vaccination. Front Immunol 2012, 3:193.
55. Frasca D., Diaz A., Romero M., Landin A., Phillips M., Lechner S., et al. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly human. Vaccine 2010, 28:8077-8084.
56. WHO (World Health Organization) Influenza 2014, http://www.who.int/mediacentre/factsheets/fs211/en/.
57. CDC (Centers for Disease Control and Prevention) Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season. Morb Mortal Wkly Rep 2013, 62:997-1000.
58. Hak E., Wei F., Nordin J., Mullooly J., Poblete S., Nichol K. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004, 189:450-458.
59. Kohlmeier J., Woodland D. Immunity to respiratory viruses. Annu Rev Immunol 2009, 27:61-82.
60. Wilkinson T.M., Li C.K.F., Chui C.S.C., Huang A.K.Y., Perkins M., Liebner J.C., et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012, 18:274-280.
61. Sridhar S., Begom S., Bermingham A., Hoschler K., Adamson W., Carman W., et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 2013, 19:1305-1312.
62. Plowden J., Renshaw-Hoelscher M., Engleman C., Katz J., Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell 2004, 3:161-167.
63. Sharma G., Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 2006, 1:253-260.
64. CDC (Centers for Disease Control and Prevention) Vaccines for older adults (60 years or older) 2013, http://www.cdc.gov/vaccines/adults/rec-vac/older-adults.html.
65. Manzoli L., Ioannidis J.P.A., Flacco M.E., De Vito C., Villari P. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother 2012, 8:851-862.
66. Haq K., McElhaney J.E. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol 2014, 29C:38-42.
67. Castilow E.M., Varga S.M., Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Future Virol 2008, 3:445-454.
68. Garg R., Latimer L., Gerdts V., Potter A., van Drunen Littel-van den Hurk S. Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunity. J Gen Virol 2014, 95:1043-1054.
69. CDC (Centers for Disease Control and Prevention) Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). Morb Mortal Wkly Rep 2010, 59:1102-1106.
70. Weinberger D.M., Shapiro E.D. Pneumoccocal conjugate vaccines for adults: resasons for optimism and for caution. Human Vaccin Immunother 2014, 10:1334-1336. PMID: 24763136.